E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/9/2017 in the Prospect News Convertibles Daily.

New Issue: Invacare prices $105 million five-year convertibles at par to yield 4.5%, up 32.5%

By Stephanie N. Rotondo

Seattle, June 9 – Invacare Corp. sold $105 million of five-year convertible senior notes at par to yield 4.5% with an initial conversion premium of 32.5%, the company said in a press release.

The deal came at the rich end of the 4.5% to 5% yield talk as well as at the rich end of the 27.5% to 32.5% premium talk.

Goldman Sachs & Co. is the bookrunner on the Rule 144A deal.

There is a $15 million 13-day over-allotment option.

Conversions will be settled in cash until the company receives shareholder approval to issue new stock. The initial conversion rate is 61.6095 shares per each $1,000 of notes, equal to an initial conversion price of $16.23 a share.

The notes are contingently convertible prior to Dec. 1, 2021 but are convertible at any time after that date.

The issue is non-callable. Holders can put the issue upon a fundamental change.

In connection with the deal, Invacare expects to enter into convertible hedge transactions with Goldman Sachs, as well as separate, privately negotiated warrant transactions.

Proceeds will be used, in part, to cover the hedging transactions. The remaining funds will be used for working capital and general corporate purposes, which may include funding portions of the company’s ongoing turnaround and addressing potential risks and contingencies.

Invacare is an Elyria, Ohio-based manufacturer and distributor of medical equipment used in non-acute care settings.

Issuer:Invacare Corp.
Securities:Convertible senior notes
Amount:$105 million
Greenshoe:$15 million
Maturity:June 1, 2022
Bookrunner:Goldman Sachs & Co.
Coupon:4.5%
Price:Par of $1,000
Yield:4.5%
Conversion premium:32.5%
Conversion price:$16.23
Conversion rate:61.6095 shares
Call options:None
Put options:Upon a fundamental change
Pricing date:June 8
Settlement date:June 14
Distribution:Rule 144A
Talk:4.5% to 5% yield, up 27.5% to 32.5%
Stock symbol:NYSE: IVC
Stock price:$12.15 as of June 8 close
Market capitalization:$389.29 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.